Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lisa Herrinton

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
JAMA Surgery|October 30, 2014
Comparative effectiveness of laparoscopic adjustable gastric banding vs laparoscopic gastric bypassDavid Arterburn, J David Powers, Sengwee Toh, et al.
Cancer|December 23, 2006
Racial differences in tumor stage and survival for colorectal cancer in an insured populationChyke A Doubeni, Terry S Field, Diana S M Buist, et al.
Arthritis Care & Research|January 3, 2013
Initiation of tumor necrosis factor α antagonists and risk of fractures in patients with selected rheumatic and autoimmune diseasesVivian K Kawai, Carlos G Grijalva, Patrick G Arbogast, et al.
Arthritis Care & Research|November 29, 2011
Changes in cotherapies after initiation of disease-modifying antirheumatic drug therapy in patients with rheumatoid arthritisVivian K Kawai, Carlos G Grijalva, Patrick G Arbogast, et al.
Journal of the National Cancer Institute. Monographs|November 17, 2005
Disparities and survival among breast cancer patientsTerry S Field, Diana S M Buist, Chyke Doubeni, et al.
Pharmacoepidemiology and Drug Safety|October 24, 2007
Early detection of adverse drug events within population-based health networks: application of sequential testing methodsJeffrey S Brown, Martin Kulldorff, K Arnold Chan, et al.
Pharmacoepidemiology and Drug Safety|January 17, 2009
Early adverse drug event signal detection within population-based health networks using sequential methods: key methodologic considerationsJeffrey S Brown, Martin Kulldorff, Kenneth R Petronis, et al.
Pharmaceutics|December 5, 2013
Drug Adverse Event Detection in Health Plan Data Using the Gamma Poisson Shrinker and Comparison to the Tree-based Scan StatisticJeffrey S Brown, Kenneth R Petronis, Andrew Bate, et al.
Inflammatory Bowel Diseases|November 28, 2013
Challenges in designing a national surveillance program for inflammatory bowel disease in the United StatesMillie D Long, Susan Hutfless, Michael D Kappelman, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
JAMA Surgery|October 30, 2014
Comparative effectiveness of laparoscopic adjustable gastric banding vs laparoscopic gastric bypassDavid Arterburn, J David Powers, Sengwee Toh, et al.
Cancer|December 23, 2006
Racial differences in tumor stage and survival for colorectal cancer in an insured populationChyke A Doubeni, Terry S Field, Diana S M Buist, et al.
Arthritis Care & Research|January 3, 2013
Initiation of tumor necrosis factor α antagonists and risk of fractures in patients with selected rheumatic and autoimmune diseasesVivian K Kawai, Carlos G Grijalva, Patrick G Arbogast, et al.
Arthritis Care & Research|November 29, 2011
Changes in cotherapies after initiation of disease-modifying antirheumatic drug therapy in patients with rheumatoid arthritisVivian K Kawai, Carlos G Grijalva, Patrick G Arbogast, et al.
Journal of the National Cancer Institute. Monographs|November 17, 2005
Disparities and survival among breast cancer patientsTerry S Field, Diana S M Buist, Chyke Doubeni, et al.
Pharmacoepidemiology and Drug Safety|October 24, 2007
Early detection of adverse drug events within population-based health networks: application of sequential testing methodsJeffrey S Brown, Martin Kulldorff, K Arnold Chan, et al.
Pharmacoepidemiology and Drug Safety|January 17, 2009
Early adverse drug event signal detection within population-based health networks using sequential methods: key methodologic considerationsJeffrey S Brown, Martin Kulldorff, Kenneth R Petronis, et al.
Pharmaceutics|December 5, 2013
Drug Adverse Event Detection in Health Plan Data Using the Gamma Poisson Shrinker and Comparison to the Tree-based Scan StatisticJeffrey S Brown, Kenneth R Petronis, Andrew Bate, et al.
Inflammatory Bowel Diseases|November 28, 2013
Challenges in designing a national surveillance program for inflammatory bowel disease in the United StatesMillie D Long, Susan Hutfless, Michael D Kappelman, et al.
Pageof 3